Kang B - Search Results

1

Deep learning model enables the discovery of a novel immunotherapeutic agent regulating the kynurenine pathway.

Kim JH, Lee WS, Lee HJ, Yang H, Lee SJ, Kong SJ, Je S, Yang HJ, Jung J, Cheon J, Kang B, Chon HJ, Kim C. Kim JH, et al. Among authors: kang b. Oncoimmunology. 2021 Nov 26;10(1):2005280. doi: 10.1080/2162402X.2021.2005280. eCollection 2021. Oncoimmunology. 2021. PMID: 34858729 Free PMC article.

2

Phase II gemcitabine and capecitabine combination therapy in recurrent or metastatic breast cancer patients pretreated with anthracycline and taxane.

Park JS, Jeung HC, Rha SY, Ahn JB, Kang B, Chon HJ, Hong MH, Lim S, Yang WI, Nam CM, Chung HC. Park JS, et al. Among authors: kang b. Cancer Chemother Pharmacol. 2014 Oct;74(4):799-808. doi: 10.1007/s00280-014-2551-4. Epub 2014 Aug 9. Cancer Chemother Pharmacol. 2014. PMID: 25107569 Clinical Trial.

3

Bone alkaline phosphatase as a surrogate marker of bone metastasis in gastric cancer patients.

Lim SM, Kim YN, Park KH, Kang B, Chon HJ, Kim C, Kim JH, Rha SY. Lim SM, et al. Among authors: kang b. BMC Cancer. 2016 Jul 4;16:385. doi: 10.1186/s12885-016-2415-x. BMC Cancer. 2016. PMID: 27377907 Free PMC article.

4

Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancer.

Kim C, Chon HJ, Kim JH, Jung M, Nam CM, Kim HS, Kang B, Chung HC, Rha SY. Kim C, et al. Among authors: kang b. Eur J Cancer. 2019 May;112:20-28. doi: 10.1016/j.ejca.2018.11.029. Epub 2019 Mar 19. Eur J Cancer. 2019. PMID: 30901609 Clinical Trial.

5

Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse events.

Yoo C, Byeon S, Bang Y, Cheon J, Kim JW, Kim JH, Chon HJ, Kang B, Kang MJ, Kim I, Hwang JE, Kang JH, Lee MA, Hong JY, Lim HY, Ryoo BY. Yoo C, et al. Among authors: kang mj, kang b, kang jh. Liver Int. 2020 Sep;40(9):2263-2271. doi: 10.1111/liv.14496. Epub 2020 May 25. Liver Int. 2020. PMID: 32449588

6

Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective study.

Kim HD, Bang Y, Lee MA, Kim JW, Kim JH, Chon HJ, Kang B, Kang MJ, Kim I, Cheon J, Hwang JE, Kang JH, Byeon S, Hong JY, Ryoo BY, Lim HY, Yoo C. Kim HD, et al. Among authors: kang mj, kang b, kang jh. Liver Int. 2020 Oct;40(10):2544-2552. doi: 10.1111/liv.14573. Epub 2020 Jul 9. Liver Int. 2020. PMID: 32563213

7

Hyperprogressive disease during PD-1 blockade in patients with advanced hepatocellular carcinoma.

Kim CG, Kim C, Yoon SE, Kim KH, Choi SJ, Kang B, Kim HR, Park SH, Shin EC, Kim YY, Kim DJ, Chung HC, Chon HJ, Choi HJ, Lim HY. Kim CG, et al. Among authors: kang b. J Hepatol. 2021 Feb;74(2):350-359. doi: 10.1016/j.jhep.2020.08.010. Epub 2020 Aug 15. J Hepatol. 2021. PMID: 32810553

8

Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer.

Lee YS, Lee WS, Kim CW, Lee SJ, Yang H, Kong SJ, Ning J, Yang KM, Kang B, Kim WR, Chon HJ, Kim C. Lee YS, et al. Among authors: kang b. J Immunother Cancer. 2020 Nov;8(2):e000857. doi: 10.1136/jitc-2020-000857. J Immunother Cancer. 2020. PMID: 33199510 Free PMC article.

9

Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: a multicenter retrospective study of the Korean Cancer Study Group (KCSG).

Park HS, Kang B, Chon HJ, Im HS, Lee CK, Kim I, Kang MJ, Hwang JE, Bae WK, Cheon J, Park JO, Hong JY, Kang JH, Kim JH, Lim SH, Kim JW, Kim JW, Yoo C, Choi HJ. Park HS, et al. Among authors: kang mj, kang b, kang jh. ESMO Open. 2021 Apr;6(2):100049. doi: 10.1016/j.esmoop.2021.100049. Epub 2021 Feb 9. ESMO Open. 2021. PMID: 33578192 Free PMC article.

10

STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.

Lee SJ, Yang H, Kim WR, Lee YS, Lee WS, Kong SJ, Lee HJ, Kim JH, Cheon J, Kang B, Chon HJ, Kim C. Lee SJ, et al. Among authors: kang b. J Immunother Cancer. 2021 Jun;9(6):e002195. doi: 10.1136/jitc-2020-002195. J Immunother Cancer. 2021. PMID: 34145029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,834 results

Search Page

Filters